Issues on clinical applications of cancer vaccines.
Disis
M L
ML
Department of Oncology, Tumor Vaccine Group, University of Washington, Seattle 98195-6527, USA.
Schiffman
K
K
D000230:Adenocarcinoma / Q000276:immunology; D019496:Cancer Vaccines / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D016233:Immunotherapy, Active; D018396:Mucin-1 / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D019496:Cancer Vaccines; D018396:Mucin-1